79091998 - ACLARUSDX

Information

• Trademark
• 79091998

• Source

• Serial Number

  79091998

• Registration Number

  4024702

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 24, 2010
  14 years ago

• Registration Date

  September 13, 2011
  13 years ago

• Transaction Date

  September 11, 2021
  3 years ago

• Status Date

  August 24, 2020
  4 years ago

• Published for Opposition Date

  June 28, 2011
  13 years ago

• Location Date

  December 05, 2014
  10 years ago

• Status Code

  404

• Current Location

  TTAB

  Employee Name

  FRYE, KIMBERLY

• Law Office Assigned Location Code

  M40

• Owners

  • Exonhit S.A.
  • ExonHit Therapeutics SA

Case File Statements

• CC0000: The color(s) red and blue is/are claimed as a feature of the mark.
• DM0000: The mark consists of the wording "ACLARUSDX", with "ACLARUS" in blue and "DX" in red".
• GS0011: Chemical preparations and compositions, namely, nucleic acids attached to a solid medium, for industrial and scientific use; chemical fissile preparations for laboratory use; chemical fissile preparations for scientific research; chemical preparations for nucleic acids attached to a solid medium, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes, namely, blood for enabling the quantification of nucleic acid content; chemicals for scientific use, other than for medical or veterinary purposes; chemical preparations or reagents for laboratory, namely, nucleic acid to screen and analyze gene expression, to identify therapeutic targets and products, and to conduct pharmacogenomic and genotoxicity research in the fields of pharmacology, food, chemistry, cosmetology, plant protection, and veterinary sciences; chemical preparations for scientific use, namely, nucleic acid libraries to screen and analyze gene expression, to identify therapeutic targets and products, and to conduct pharmacogenomic and genotoxicity research in the fields of pharmacology, food, chemistry, cosmetology, plant protection, and veterinary sciences; chemical preparations for scientific use, namely, DNA biochips for decoding genes affected by the Alzheimer's disease or revealing the transcriptomic signature of patients affected with Alzheimer's disease, and DNA chips to make visible and analyze gene expression in the fields of human and pharmacological medicine and veterinary science
• GS0051: Pharmaceutical preparations for treating neurodegenerative diseases, particularly Alzheimer's disease; diagnostic reagents and media for medical use, namely, reagents and media for use in testing blood biomarkers, to enable the identification of patients suffering from Alzheimer's disease or at risk of developing the disease and for enabling the identification of patients responding to specific treatments; acidic biological preparations and products for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing Alzheimer's disease; capsules for diagnostic tests and medicines sold empty; chemico-pharmaceutical preparations for diagnosing, preventing and treating Alzheimer's disease; biopharmaceutical preparations for diagnosing, preventing and treating Alzheimer's disease; chemicals for medical, pharmaceutical or veterinary purposes, namely, chemicals for diagnosing neurodegenerative diseases, especially Alzheimer's disease; medical and clinical diagnosis testing kits comprised of nucleic acid banks, nucleic acids on DNA chips and testing probes; DNA libraries and RNA libraries for medical diagnostic purposes; nucleic acid sequences for use on biochips, for medical and medical diagnostic use, namely, for decoding genes affected by Alzheimer's disease or revealing the transcriptomic signature of patients suffering from Alzheimer's disease; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzyme substrates used as ingredients in medicines for treatment of Alzheimer's disease; reagents contained in diagnostic test kits for taking blood samples, for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions
• GS0101: Surgical, medical, dental and veterinary apparatus and instruments, namely, apparatus and instruments for use in identifying, assessing the seriousness of, assessing the prognoses of, measuring the progression of and measuring the conversion of neurodegenerative diseases such as Alzheimer's; medical apparatus using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus for medical diagnostic purposes, namely, kits for taking blood samples comprising medical instruments for taking blood, DNA chips for diagnosing Alzheimer's disease, and material required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions; spoons for medicines; containers specially adapted for the application of medicines, namely, bags and pouches used in the delivery of medication; probes for medical purposes; syringes for medical purposes; galvanic therapeutic devices for diagnosing neurodegenerative diseases, especially Alzheimer's disease
• GS0421: Research and development for others of pharmaceutical molecules or biological markers and medicines for diagnosing and treating neurodegenerative diseases; chemical analyses; chemical research; chemical services, namely, analysis of RNA genes, tissues, and blood samples; biotechnological project studies to identify people suffering from Alzheimer's disease and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely, quantification of nucleic acid content for medical and scientific research purposes
• GS0441: Medical services; veterinary services; medical assistance; consulting in the fields of biotechnology and pharmacy, namely, to assist in the selection of Alzheimer's sufferers for clinical trials and to offer personalized treatments; hospitals; pharmacist's services to make up prescriptions; pharmaceutical advice; medical services, namely, facilitating the diagnosis and care of geriatric patients and patients with neurodegenerative diseases; health care; telemedicine services
• PM0001: ACLARUS DX

Case File Event Statements

• 9/10/2021 - 3 years ago

  38 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENC

• 9/10/2021 - 3 years ago

  37 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH

• 9/25/2015 - 9 years ago

  36 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT

• 9/2/2015 - 9 years ago

  35 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS

• 9/2/2015 - 9 years ago

  34 - INVALIDATION PROCESSED Type: INPC

• 8/5/2015 - 9 years ago

  33 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 12/5/2014 - 10 years ago

  32 - CANCELLED SECTION 7-TOTAL Type: C7..

• 12/5/2014 - 10 years ago

  31 - CANCELLATION TERMINATED NO. 999999 Type: CANT

• 12/3/2014 - 10 years ago

  30 - CANCELLATION DENIED NO. 999999 Type: CAND

• 10/24/2014 - 10 years ago

  29 - CANCELLATION INSTITUTED NO. 999999 Type: PETC

• 5/19/2013 - 11 years ago

  28 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 12/23/2011 - 13 years ago

  27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 12/23/2011 - 13 years ago

  26 - FINAL DISPOSITION PROCESSED Type: FIMP

• 12/13/2011 - 13 years ago

  25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 10/15/2011 - 13 years ago

  24 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 9/13/2011 - 13 years ago

  23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/28/2011 - 13 years ago

  22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/28/2011 - 13 years ago

  21 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/26/2011 - 13 years ago

  20 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 5/26/2011 - 13 years ago

  19 - ASSIGNED TO LIE Type: ALIE

• 5/12/2011 - 13 years ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/12/2011 - 13 years ago

  17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/12/2011 - 13 years ago

  16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 5/12/2011 - 13 years ago

  15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/12/2011 - 13 years ago

  14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 4/26/2011 - 13 years ago

  13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 4/26/2011 - 13 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/26/2011 - 13 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/26/2011 - 13 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/27/2011 - 13 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 2/9/2011 - 13 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 2/9/2011 - 13 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 2/9/2011 - 13 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 2/8/2011 - 13 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/8/2011 - 13 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 2/4/2011 - 13 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/4/2011 - 13 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 2/3/2011 - 13 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR